BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34843659)

  • 21. Incretin levels in polycystic ovary syndrome.
    Vrbikova J; Hill M; Bendlova B; Grimmichova T; Dvorakova K; Vondra K; Pacini G
    Eur J Endocrinol; 2008 Aug; 159(2):121-7. PubMed ID: 18511472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a phase advance and phase delay of the 24-h cycle on energy metabolism, appetite, and related hormones.
    Gonnissen HK; Rutters F; Mazuy C; Martens EA; Adam TC; Westerterp-Plantenga MS
    Am J Clin Nutr; 2012 Oct; 96(4):689-97. PubMed ID: 22914550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery.
    Martinussen C; Veedfald S; Dirksen C; Bojsen-Møller KN; Svane MS; Wewer Albrechtsen NJ; van Hall G; Kristiansen VB; Fenger M; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2020 Jun; 318(6):E956-E964. PubMed ID: 32182123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The incretin effect in cats: comparison between oral glucose, lipids, and amino acids.
    Gilor C; Graves TK; Gilor S; Ridge TK; Weng HY; Dossin O
    Domest Anim Endocrinol; 2011 May; 40(4):205-12. PubMed ID: 21397435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GLP-1 and GIP Levels in Patients With Hyperthyroidism: The Effect of Antithyroid Treatment.
    Cira DK; Sari R; Ozdem S; Yilmaz N; Bozkurt S
    Ann Pharmacother; 2017 Aug; 51(8):663-668. PubMed ID: 28452237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute effects of delayed-release hydrolyzed pine nut oil on glucose tolerance, incretins, ghrelin and appetite in healthy humans.
    Sørensen KV; Korfitzen SS; Kaspersen MH; Ulven ER; Ekberg JH; Bauer-Brandl A; Ulven T; Højlund K
    Clin Nutr; 2021 Apr; 40(4):2169-2179. PubMed ID: 33059911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects.
    Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3309-17. PubMed ID: 20410219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms Regulating Insulin Response to Intragastric Glucose in Lean and Non-Diabetic Obese Subjects: A Randomized, Double-Blind, Parallel-Group Trial.
    Meyer-Gerspach AC; Cajacob L; Riva D; Herzog R; Drewe J; Beglinger C; Wölnerhanssen BK
    PLoS One; 2016; 11(3):e0150803. PubMed ID: 26942445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Piromelatine, a novel melatonin receptor agonist, stabilizes metabolic profiles and ameliorates insulin resistance in chronic sleep restricted rats.
    She M; Hu X; Su Z; Zhang C; Yang S; Ding L; Laudon M; Yin W
    Eur J Pharmacol; 2014 Mar; 727():60-5. PubMed ID: 24486392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF; Nilas L; Madsbad S; Holst JJ
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The incretin effect in critically ill patients: a case-control study.
    Nielsen ST; Janum S; Krogh-Madsen R; Solomon TP; Møller K
    Crit Care; 2015 Nov; 19():402. PubMed ID: 26567860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical control of obesity and diabetes: the role of intestinal vs. gastric mechanisms in the regulation of body weight and glucose homeostasis.
    Patel RT; Shukla AP; Ahn SM; Moreira M; Rubino F
    Obesity (Silver Spring); 2014 Jan; 22(1):159-69. PubMed ID: 23512969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mixed Meal and Intravenous L-Arginine Tests Both Stimulate Incretin Release Across Glucose Tolerance in Man: Lack of Correlation with β Cell Function.
    Ruetten H; Gebauer M; Raymond RH; Calle RA; Cobelli C; Ghosh A; Robertson RP; Shankar SS; Staten MA; Stefanovski D; Vella A; Wright K; Fryburg DA;
    Metab Syndr Relat Disord; 2018 Oct; 16(8):406-415. PubMed ID: 30117761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of long-term dipeptidyl peptidase-IV inhibition on body composition and glucose tolerance in high fat diet-fed mice.
    Liu X; Harada N; Yamane S; Kitajima L; Uchida S; Hamasaki A; Mukai E; Toyoda K; Yamada C; Yamada Y; Seino Y; Inagaki N
    Life Sci; 2009 Jun; 84(25-26):876-81. PubMed ID: 19358859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postprandial plasma incretin hormones in exercise-trained versus untrained subjects.
    Weiss EP; Royer NK; Fisher JS; Holloszy JO; Fontana L
    Med Sci Sports Exerc; 2014 Jun; 46(6):1098-103. PubMed ID: 24576859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response of incretins (GIP and GLP-1) to an oral glucose load in female and male subjects with normal glucose tolerance.
    Matsuo T; Kusunoki Y; Katsuno T; Ikawa T; Akagami T; Murai K; Miuchi M; Miyagawa J; Namba M
    Diabetes Res Clin Pract; 2014 Nov; 106(2):e25-9. PubMed ID: 25271113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Sleeve Gastrectomy and Gastric Bypass on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients: a 2-Year Follow-up.
    Griffo E; Cotugno M; Nosso G; Saldalamacchia G; Mangione A; Angrisani L; Rivellese AA; Capaldo B
    Obes Surg; 2016 Jun; 26(6):1247-53. PubMed ID: 26435537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections.
    Nauck MA; Siemsglüss J; Orskov C; Holst JJ
    Z Gastroenterol; 1996 Mar; 34(3):159-66. PubMed ID: 8650968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 24-h severe energy restriction impairs postprandial glycaemic control in young, lean males.
    Clayton DJ; Biddle J; Maher T; Funnell MP; Sargeant JA; King JA; Hulston CJ; Stensel DJ; James LJ
    Br J Nutr; 2018 Nov; 120(10):1107-1116. PubMed ID: 30401004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men.
    Matikainen N; Björnson E; Söderlund S; Borén C; Eliasson B; Pietiläinen KH; Bogl LH; Hakkarainen A; Lundbom N; Rivellese A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
    PLoS One; 2016; 11(1):e0145890. PubMed ID: 26752550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.